Premium
Depression of cell‐mediated immunity in plasmacytoma‐bearing mice
Author(s) -
RUSZALAMALLON VERONICA,
SILVA JILLIAN,
LUMANGLAS ARACELI L.,
DURR FREDERICK E.,
WANG BOSCO SHANG
Publication year - 1991
Publication title -
immunology and cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.999
H-Index - 104
eISSN - 1440-1711
pISSN - 0818-9641
DOI - 10.1038/icb.1991.3
Subject(s) - plasmacytoma , immune system , immunology , splenocyte , immunity , cellular immunity , biology , population , lymphocyte , t lymphocyte , cytolysis , antigen , in vitro , medicine , multiple myeloma , cytotoxic t cell , biochemistry , environmental health
Summary Previous reports have documented that mice bearing plasmacytomas (PC) are suppressed in their ability to mount a primary antibody response, whereas cellular immunity appears to be normal. Studies presented here provide evidence that T cell responsiveness is also depressed in BALB/c mice bearing the Lieberman plasmacytoma (Lpc‐1). For instance, splenocytes from mice bearing large tumours were impaired in their in vitro ability to respond to the T cell mitogen, mount an appropriate alloreactive cytolytic T lymphocyte response, and produce interleukin‐2 (IL‐2). A population of suppressor cells was detected in the spleens 7 days after tumour implantation as evidenced by their ability to prevent normal splenocytes not only from responding to antigens in mixed lymphocyte culture, but also from producing IL‐2. A similar inhibitory effect was observed with culture supernatants of these cells, indicating the existence of a soluble suppressive factor. Therefore, the present study demonstrates that cellular immune responses are impaired in mice bearing Lpc‐1 tumours and that this effect may be due to the generation of suppressor cells and/or a suppressive factor.